FDA approves Rexulti to treat schizophrenia and as an add‐on to an antidepressant to treat major depressive disorder

Publisher: John Wiley & Sons Inc

E-ISSN: 1556-7567|17|9|8-8

ISSN: 1527-8395

Source: THE BROWN UNIVERSITY CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY UPDATE, Vol.17, Iss.9, 2015-09, pp. : 8-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract